FDA Declines Approval for Omecamtiv Mecarbil in HFrEF ...Middle East

Medscape - News
Citing a lack of efficacy data, the FDA has declined to approve omecamtiv mecarbil (Cytokinetics) for treatment of adults with chronic heart failure with reduced ejection fraction. News Alerts

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Declines Approval for Omecamtiv Mecarbil in HFrEF )

Also on site :